Furthermore, tumors exhibited upregulation of NGF and CHRM4 mRNA expressions were inversely associated with patients with low prostate-specific antigen (PSA) levels in the Taylor clinical prostate cancer dataset30 (Fig. 6f). This evidence concerns the gene NGF and prostate cancer.